Tom LeBlanc


Palliative Care Needed Alongside Aggressive Cancer Treatment

February 26, 2016

After leading a study that patients with acute myeloid leukemia who receive induction chemotherapy are quite distressed, Tom LeBlanc, hematologic malignancy specialist at Duke Cancer Institute, decided more palliative care should be offered alongside treatment for the disease.